Market Cap 151.72B
Revenue (ttm) 16.75B
Net Income (ttm) 1.85B
EPS (ttm) N/A
PE Ratio 35.20
Forward PE 34.22
Profit Margin 11.07%
Debt to Equity Ratio 0.51
Volume 6,798,300
Avg Vol 9,324,410
Day's Range N/A - N/A
Shares Out 1.48B
Stochastic %K 60%
Beta 0.61
Analysts Strong Sell
Price Target $126.26

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal sur...

Industry: Medical Devices
Sector: Healthcare
Phone: 508 683 4000
Address:
300 Boston Scientific Way, Marlborough, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 6:43 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BSX Current Share Price: $103.36 Contracts: $BSX December 18, 2026 $105 Calls Scale in: $11.90- $14.55 Scale out: $18.51-$23.80 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
humphreystone
humphreystone Oct. 24 at 10:31 PM
$BSX BSX - Riding on the gap up Volume: Neutral. Price Action: Broken downtrend, $94 support. Indicators: Ichimoku bullish, MACD & DMI bullish. StochRSI near overbought. Setup: Short/Long breakout. Possible reversal. Entries: $104, $100. Stop: $94. Targets: $109, $114, $120, $127, $139, $300.
0 · Reply
jewell69
jewell69 Oct. 24 at 7:14 PM
$BSX THROWING GOOD MONEY AFTER BAD 10/24/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 40 $101.30 -$4.X,052.00 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60 TOOK PROFITS AT 104.33 ON 10/22
0 · Reply
jewell69
jewell69 Oct. 24 at 5:23 PM
trying to throw good money after bad 40 at 101.30 now 101.47 x .49 10/24/25 1:21 pm edt $BSX recent buy 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 4:46 PM
Enter: $BSX NOV 14 2025 $103 CALLS Buy in Price: $2.30 - $2.95 Take Profit: $4.16 Stop Bleeding: $2.60 ROI Potential: 41% https://moneygroup.us/
0 · Reply
justinaugustus
justinaugustus Oct. 23 at 10:47 PM
$BSX I'm a sucker for an epic losing streak BSX is on an 8-session losing streak, its longest since late 2022. As a mean reversion trader, this suggests a buy opportunity. While a similar setup recently led to a long, frustrating trade, it was ultimately profitable. This time, I plan a quicker exit—I'll close on the first profitable close after today. Entry is at 98.37. This reflects my own view, not investment advice. Always do your own research and invest at your own risk.https://stocktwits.com/GaryBrown7417/message/632828520
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 9:05 PM
UBS has adjusted their stance on Boston Scientific ( $BSX ), setting the rating to Buy with a target price of 135 → 140.
0 · Reply
jewell69
jewell69 Oct. 23 at 7:12 PM
$BSX RE ENTRY 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60 10/22/2025 Sell Trade Details BSX BOSTON SCIENTIFIC CORP 55 $104.33 $0.01 $5,738.14 09/15/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 28 $102.03 -$2.X,856.84 09/12/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 27 $102.72 -$2.X,773.44
0 · Reply
jewell69
jewell69 Oct. 23 at 3:45 PM
$BSX trying to re-enter 103.10 now 103.81 at 11:43 am edt. recent profit taken yesterday 10/22 as shown below 10/22/2025 Sell Trade Details BSX BOSTON SCIENTIFIC CORP 55 $104.33 $0.01 $5,738.14
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 3:13 PM
Enter: $BSX NOV 14 2025 $104 CALLS Buy in Price: $2.68 - $2.81 Take Profit: $6.32 Stop Bleeding: $2.36 ROI Potential: 136% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
Latest News on BSX
Boston Scientific announces results for third quarter 2025

Oct 22, 2025, 6:30 AM EDT - 3 days ago

Boston Scientific announces results for third quarter 2025


Boston Scientific buys Nalu Medical for $533 million

Oct 17, 2025, 7:09 AM EDT - 8 days ago

Boston Scientific buys Nalu Medical for $533 million


9 Stocks to Buy Before Their Earnings Reports

Oct 13, 2025, 2:53 PM EDT - 11 days ago

9 Stocks to Buy Before Their Earnings Reports

ADBE CSCO GM OKTA ZM


4 Top AI-Powered Healthcare Stocks

Oct 9, 2025, 5:00 AM EDT - 16 days ago

4 Top AI-Powered Healthcare Stocks

OPRX VEEV ZEPP


Top 3 Health Care Stocks That May Explode In September

Sep 19, 2025, 7:01 AM EDT - 5 weeks ago

Top 3 Health Care Stocks That May Explode In September

ATYR RVPH


Boston Scientific Corporation Is Expensive But Worth It

Aug 9, 2025, 8:53 AM EDT - 2 months ago

Boston Scientific Corporation Is Expensive But Worth It


Cramer's Stop Trading: Boston Scientific

Jul 23, 2025, 10:46 AM EDT - 3 months ago

Cramer's Stop Trading: Boston Scientific


Boston Scientific announces results for second quarter 2025

Jul 23, 2025, 6:30 AM EDT - 3 months ago

Boston Scientific announces results for second quarter 2025


I'm Buying Dividend Aristocrats At Bargain Basement Prices

Jun 17, 2025, 8:00 AM EDT - 4 months ago

I'm Buying Dividend Aristocrats At Bargain Basement Prices

JNJ KO MDT PEP


What's Happening With Boston Scientific Stock?

Jun 16, 2025, 11:00 AM EDT - 4 months ago

What's Happening With Boston Scientific Stock?


3 Growth Stocks That Aren't the Magnificent 7

Jun 6, 2025, 2:42 PM EDT - 5 months ago

3 Growth Stocks That Aren't the Magnificent 7

CYBR


Boston Scientific announces results for first quarter 2025

Apr 23, 2025, 6:30 AM EDT - 6 months ago

Boston Scientific announces results for first quarter 2025


Boston Scientific announces agreement to acquire SoniVie Ltd.

Mar 3, 2025, 6:58 AM EST - 8 months ago

Boston Scientific announces agreement to acquire SoniVie Ltd.


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 6:43 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BSX Current Share Price: $103.36 Contracts: $BSX December 18, 2026 $105 Calls Scale in: $11.90- $14.55 Scale out: $18.51-$23.80 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
humphreystone
humphreystone Oct. 24 at 10:31 PM
$BSX BSX - Riding on the gap up Volume: Neutral. Price Action: Broken downtrend, $94 support. Indicators: Ichimoku bullish, MACD & DMI bullish. StochRSI near overbought. Setup: Short/Long breakout. Possible reversal. Entries: $104, $100. Stop: $94. Targets: $109, $114, $120, $127, $139, $300.
0 · Reply
jewell69
jewell69 Oct. 24 at 7:14 PM
$BSX THROWING GOOD MONEY AFTER BAD 10/24/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 40 $101.30 -$4.X,052.00 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60 TOOK PROFITS AT 104.33 ON 10/22
0 · Reply
jewell69
jewell69 Oct. 24 at 5:23 PM
trying to throw good money after bad 40 at 101.30 now 101.47 x .49 10/24/25 1:21 pm edt $BSX recent buy 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 4:46 PM
Enter: $BSX NOV 14 2025 $103 CALLS Buy in Price: $2.30 - $2.95 Take Profit: $4.16 Stop Bleeding: $2.60 ROI Potential: 41% https://moneygroup.us/
0 · Reply
justinaugustus
justinaugustus Oct. 23 at 10:47 PM
$BSX I'm a sucker for an epic losing streak BSX is on an 8-session losing streak, its longest since late 2022. As a mean reversion trader, this suggests a buy opportunity. While a similar setup recently led to a long, frustrating trade, it was ultimately profitable. This time, I plan a quicker exit—I'll close on the first profitable close after today. Entry is at 98.37. This reflects my own view, not investment advice. Always do your own research and invest at your own risk.https://stocktwits.com/GaryBrown7417/message/632828520
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 9:05 PM
UBS has adjusted their stance on Boston Scientific ( $BSX ), setting the rating to Buy with a target price of 135 → 140.
0 · Reply
jewell69
jewell69 Oct. 23 at 7:12 PM
$BSX RE ENTRY 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60 10/22/2025 Sell Trade Details BSX BOSTON SCIENTIFIC CORP 55 $104.33 $0.01 $5,738.14 09/15/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 28 $102.03 -$2.X,856.84 09/12/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 27 $102.72 -$2.X,773.44
0 · Reply
jewell69
jewell69 Oct. 23 at 3:45 PM
$BSX trying to re-enter 103.10 now 103.81 at 11:43 am edt. recent profit taken yesterday 10/22 as shown below 10/22/2025 Sell Trade Details BSX BOSTON SCIENTIFIC CORP 55 $104.33 $0.01 $5,738.14
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 23 at 3:13 PM
Enter: $BSX NOV 14 2025 $104 CALLS Buy in Price: $2.68 - $2.81 Take Profit: $6.32 Stop Bleeding: $2.36 ROI Potential: 136% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
erevnon
erevnon Oct. 23 at 2:56 PM
Morgan Stanley maintains Boston Scientific $BSX at Overweight and raises the price target from $125 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 2:32 PM
Truist Securities has updated their rating for Boston Scientific ( $BSX ) to Buy with a price target of 130.
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 1:18 PM
Wells Fargo updates rating for Boston Scientific ( $BSX ) to Overweight, target set at 124 → 125.
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 1:13 PM
Morgan Stanley has adjusted their stance on Boston Scientific ( $BSX ), setting the rating to Overweight with a target price of 125 → 130.
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 1:02 PM
Canaccord Genuity updates rating for Boston Scientific ( $BSX ) to Buy, target set at 132.
0 · Reply
TheVulcanDevilWhale
TheVulcanDevilWhale Oct. 23 at 2:57 AM
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 10:35 PM
Enter: $BSX NOV 14 2025 $104 CALLS Buy in Price: $2.80 - $3.10 Take Profit: $4.00 Stop Bleeding: $2.73 ROI Potential: 29% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 7:15 PM
$BSX strong watch for today..
0 · Reply
lecorb
lecorb Oct. 22 at 7:01 PM
$BSX Boston Scientific raises 2025 organic growth guidance to 15.5% amid WATCHMAN and EP momentum https://seekingalpha.com/news/4507045-boston-scientific-raises-2025-organic-growth-guidance-to-15_5-percent-amid-watchman-and-ep?mailingid=42119184&messageid=2900&position=rta_news_most_popular_main_2_textlink&serial=42119184.774&source=email_2900&utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha&utm_term=42119184.774
0 · Reply
ZacksResearch
ZacksResearch Oct. 22 at 6:49 PM
$BSX Q3 earnings beat — but is it enough to fuel a rally? 🤔 🔹 Adjusted EPS of 75 cents, up 19% year over year, surpasses estimates by 5.6%. 🔹 Revenue climbed 20.3% year over year on a reported basis, beating expectations with strong growth across segments. Optimistic full-year outlook update — discover the details here 👉 https://www.zacks.com/stock/news/2773960/boston-scientific-beats-on-q3-earnings-raises-2025-view-stock-up?cid=sm-stocktwits-2-2773960-body-17200&ADID=SYND_STOCKTWITS_TWEET_2_2773960_BODY_17200
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 5:59 PM
$BSX showing high relative strength..
0 · Reply
ZacksResearch
ZacksResearch Oct. 22 at 5:49 PM
$BSX just delivered a clean beat and raised guidance — classic strength move. Q3 EPS jumped 19%, and management boosted its 2025 sales and EPS outlook — that’s confidence backed by performance. Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2773960/boston-scientific-beats-on-q3-earnings-raises-2025-view-stock-up?cid=sm-stocktwits-2-2773960-teaser-17196&ADID=SYND_STOCKTWITS_TWEET_2_2773960_TEASER_17196
0 · Reply